comparemela.com
  1. Home
  2. Live Updates
  3. Month Exclusive Period - Breaking News

Month Exclusive Period News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Awakn Life Sciences Corp : Awakn Life Sciences Signs Agreement with a Leading Drug Development Company to Deepen IP Moat for Its Lead Program

Agreement Provides 12-Month Exclusive Period to Agree in-Licensing Deal for Proprietary Formulation of Ketamine Toronto, Ontario (Newsfile Corp. - August 25, 2022) - Awakn Life Sciences Corp. (NEO: AWKN)

United kingdomUnited statesGordo whittakerAnne donohoeTesfa mekonenAnthony tennysonLinkedin facebookAwakn life sciencesStrategic communicationsNewsfile corpAwakn life sciences corpAgreement providesMonth exclusive periodLicensing dealProprietary formulationLife sciences

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.